Regular FeNO* testing of asthma patients with NIOX®, measures allergic airway inflammation (Th2 driven) and helps to:
Reveal if your patient will benefit from ICS** treatment
Optimise ICS dose and reduce exacerbations up to 50%
Detect patient non-adherence to ICS** while improving asthma outcomes and reducing costs. *FeNO (Fractional exhaled nitric oxide) **ICS (Inhaled corticosteroids)
Inflammation measurement with NIOX® offers personalised asthma management that can dramatically improve the treatment and care of your patients.
Several underlying diseases can present symptoms similar to asthma. Therefore, a correct diagnosis relies on establishing whether or not the patient is characterised by allergic airway inflammation.
Until recently, diagnostic devices have not been able to convey a complete clinical overview and clearly identify the underlying cause of the symptoms.
Consequently, patients that are not suffering from asthma have received unnecessary or inadequate treatment.
Patients with asthma symptoms due to allergic inflammation will respond favourably to inhaled corticosteroids, while those who are suffering from other airway disorders may not.
Measuring FeNO helps to eliminate the uncertainties and discrepancies that contribute to asthma morbidity and mortality, including incorrect diagnosis and poor adherence to treatment.
Calibration and Maintenance-free instrument.
Validated against the Gold Standard Laboratory Instruments (Chemiluminescence).
All FeNO-values quality assured.
Validated repeatability means you only need perform a single measurement whereas other devices require at least two measurements.
Inhalation of NO-free air. NIOX VERO removes ambient NO, which ensures accuracy and follows the recommendations by ATS/ERS.
Instrument memory of up to 3000 measurements which can easily be transferred to the NIOX VERO Data Management Program on a PC.
Infection control with a disposable bacterial and viral filter prevents contamination of the device and between patients.
Niche Medical | Solutions in Respiratory Care & Diagnosis
We are a progressive Australian owned Company with decades of experience in the medical industry. We strive to achieve long and happy relationships with our Customers.
The Niche Medical team specialise in the supply and support of market leading products to the Australian Healthcare Industry. We actively support our customers to further their knowledge to improve patient care.
Our primary fields of expertise are in Respiratory Medicine and Neonatal Intensive Care. We have an innovative product range supported by scientific evidence endorsed by key opinion leaders and include the following:
Pulmonary Function Testing
Neonatal Intensive Care
High Flow Oxygen Therapy
Aerosol and Oxygen Therapy
Niche Medical's strong desire for growth drives our search for a pipeline of leading edge products.
The dynamic team at Niche Medical share common core values such as a dedication to Customer care, a sense of fair play, team pride and a good sense of humour.
We distribute the following products exclusively in Australia:
EasyOne Diagnostic Spirometers, Bedfont Smokerlyzer CO (Carbon Monoxide) Monitors, Bedfont ToxCO Monitors for CO (Carbon Monoxide) Poisoning, Vapotherm High-Flow Humidification via Nasal Cannula, EasyOne Pro Portable DLCO System, Mini-Wright Digital FEV1 / PEF Meters, Hans Rudolph Volume Calibration Syringes, One Way Valve Mouthpieces, LiteAire Disposable Cardboard Spacers, Ultrasonic Nebulisers, Portable Ultrasonic Nebuliser, Sidestream and Ventstream Jet Nebulisers, Porta-Neb Compressor System, Sidestream Jet Nebuliser Kits, System 22 Aerosol / Oxygen Mask Kits and Tracheostomy Masks.